 |
|
|
| |
Geographical Disparities in Clinical Outcomes
of Severe COVID-19 Patients Treated With Remdesivir
|
| |
| |
IDWeek 2020 Oct 21-25 virtual
George Diaz,1Jose R. Arribas,2Philip A. Robinson,3Anna M. Cattelan,4Karen T. Tashima,5Owen T.-Y. Tsang,6Yao-Shen Chen,7Devi SenGupta,8Elena Vendrame,8Christiana Blair,8Anand P. Chokkalingam,8Anu O. Osinusi,8Diana M. Brainard,8Bum S. Chin,9Christoph Spinner,10Gerard J. Criner,11Jose Muņoz,12David C. Boon Lye,13Robert L. Gottlieb14
1Providence Regional Medical Center Everett, Everett, WA, USA; 2Hospital Universitario La Paz, Madrid, Spain; 3Hoag Memorial Hospital Presbyterian, Newport Beach, CA, USA; 4UOC Malattie Infettive e Tropicali, Azienda Ospedaliera di Padova, Italy;5The Miriam Hospital, Providence, RI, USA; 6Princess Margaret Hospital, Hong Kong; 7Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; 8Gilead Sciences, Inc., Foster City, CA, USA; 9National Medical Center, Seoul, South Korea; 10Temple University Hospital, Philadelphia, PA, USA; 11Technical University of Munich, School of Medicine, University Hospital rechtsder Isar, Munich, Germany;
12Hospital Clinic de Barcelona, Barcelona, Spain; 13National Centre for Infectious Diseases, Tan Tock Seng Hospital, Singapore; 14Baylor University Medical Center, Dallas, TX, USA
|
| |
|
|
|
|
|
